Plavix patent upheld by Federal Circuit
The US Court of Appeals for the Federal Circuit has upheld a US patent for the popular blood clot-inhibitor Plavix in another victory for branded pharmaceutical companies
A three-judge panel last week affirmed the US District Court for the Southern District of New York's June 2007 ruling in favour of Bristol-Myers Squibb and Sanofi Aventis, which held that US patent number 4,847,265 was valid and enforceable....
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.